A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma

Publication | Open Access

DOI Full Paper Access

Citations

References

2020

Year

Tracy Murray Stewart, Daniel D. Von Hoff, Michael L. Fitzgerald, Laurence J. Marton, Carlos H.R. Becerra, Thomas E. Boyd, Paul Conkling, Lawrence Garbo, Robert M. Jotte, Donald Richards,

Cancer Chemotherapy and Pharmacology

Dose-escalation StudyMedicinePharmacologyPhase Ib MulticenterPolyamine Analogue Pg-11047PharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyDrug Discovery